By vgreene, 26 March, 2020 Tocilizumab 8 mg/kg IV (max: 800 mg) x1 dose plus up to 1 additional dose if sx worsen or no improvement
By vgreene, 26 March, 2020 Randomized, double-blind trial of hospitalized adults w/ COVID-19 pneumonia and O2 sat ≤93%
By vgreene, 26 March, 2020 Intermediate-Size Patient Population Expanded Access Treatment Protocol for Coronavirus Disease 2019 (COVID-19) Remdesivir (RDV; GS-5734™), NCT04302766
By vgreene, 26 March, 2020 Active: Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment
By vgreene, 26 March, 2020 Location: Various sites in US and Hong Kong, South Korea, Singapore, Taiwan